FTC Wants to Block the Amgen-Horizon Deal: Is Pfizer's Acquisition of Seagen at Risk, Too?

[cafead]

via

• There isn't much overlap between Amgen's business and Horizons', but that isn't stopping the FTC from looking to block the deal.
• Pfizer has a strong oncology portfolio and is planning to acquire Seagen, a company with an entire focus on cancer treatments.
• Pfizer's deal is much larger than the Amgen-Horizons acquisition.

article source